These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8461467)

  • 1. Complement and virus-specific antibody-dependent infection of normal B lymphocytes by human immunodeficiency virus type 1.
    Gras G; Richard Y; Roques P; Olivier R; Dormont D
    Blood; 1993 Apr; 81(7):1808-18. PubMed ID: 8461467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion.
    Boyer V; Desgranges C; Trabaud MA; Fischer E; Kazatchkine MD
    J Exp Med; 1991 May; 173(5):1151-8. PubMed ID: 1827139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptors.
    Robinson WE; Montefiori DC; Mitchell WM
    Virology; 1990 Apr; 175(2):600-4. PubMed ID: 2327077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV.
    Delibrias CC; Kazatchkine MD; Fischer E
    Scand J Immunol; 1993 Aug; 38(2):183-9. PubMed ID: 8346417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21).
    Montefiori DC; Stewart K; Ahearn JM; Zhou J; Zhou J
    J Virol; 1993 May; 67(5):2699-706. PubMed ID: 8474169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody mediated enhancement of HIV-1 infection of an EBV transformed B cell line is CD4 dependent.
    Nottet HS; Janse I; De Vos NM; Bakker LJ; Visser MR; Verhoef J
    Eur J Clin Invest; 1992 Oct; 22(10):670-5. PubMed ID: 1459171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement-activating antibodies in sera from infected individuals and vaccinated volunteers that target human immunodeficiency virus type 1 to complement receptor type 1 (CR1, CD35).
    Zhou J; Montefiori DC
    Virology; 1996 Dec; 226(1):13-21. PubMed ID: 8941318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic analysis of complement receptor 2+ T lymphocytes: reduced expression on CD4+ cells in HIV-infected persons.
    June RA; Landay AL; Stefanik K; Lint TF; Spear GT
    Immunology; 1992 Jan; 75(1):59-65. PubMed ID: 1371493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligation of CR1 (C3b receptor, CD35) on CD4+ T lymphocytes enhances viral replication in HIV-infected cells.
    Mouhoub A; Delibrias CC; Fischer E; Boyer V; Kazatchkine MD
    Clin Exp Immunol; 1996 Nov; 106(2):297-303. PubMed ID: 8918576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsonized HIV independently of CD4.
    Thieblemont N; Haeffner-Cavaillon N; Ledur A; L'Age-Stehr J; Ziegler-Heitbrock HW; Kazatchkine MD
    Clin Exp Immunol; 1993 Apr; 92(1):106-13. PubMed ID: 7682158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus type 1 infection in a human, Epstein-Barr virus-transformed B-lymphocytic cell line.
    Gras GS; Dormont D
    J Virol; 1991 Jan; 65(1):541-5. PubMed ID: 1845908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolates.
    Chehimi J; Bandyopadhyay S; Prakash K; Perussia B; Hassan NF; Kawashima H; Campbell D; Kornbluth J; Starr SE
    J Virol; 1991 Apr; 65(4):1812-22. PubMed ID: 1672164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant gp120 specifically enhances tumor necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors.
    Rieckmann P; Poli G; Fox CH; Kehrl JH; Fauci AS
    J Immunol; 1991 Nov; 147(9):2922-7. PubMed ID: 1918999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection.
    Willey S; Aasa-Chapman MM; O'Farrell S; Pellegrino P; Williams I; Weiss RA; Neil SJ
    Retrovirology; 2011 Mar; 8():16. PubMed ID: 21401915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced in vitro human immunodeficiency virus type 1 replication in B cells expressing surface antibody to the TM Env protein.
    Tani Y; Donoghue E; Sharpe S; Boone E; Lane HC; Zolla-Pazner S; Cohen DI
    J Virol; 1994 Mar; 68(3):1942-50. PubMed ID: 8107254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of human monoclonal antibody-producing B cell lines to infection by human immunodeficiency virus.
    Shepherd AJ; Boyd JE; Hogg CL; Aw D; James K
    Hum Antibodies Hybridomas; 1992 Oct; 3(4):168-76. PubMed ID: 1335786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis.
    Ho JL; He S; Hu A; Geng J; Basile FG; Almeida MG; Saito AY; Laurence J; Johnson WD
    J Exp Med; 1995 Apr; 181(4):1493-505. PubMed ID: 7699332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.
    Yang OO; Kalams SA; Rosenzweig M; Trocha A; Jones N; Koziel M; Walker BD; Johnson RP
    J Virol; 1996 Sep; 70(9):5799-806. PubMed ID: 8709196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism(s) promoting HIV-1 infection of primary unstimulated T lymphocytes in autologous B cell/T cell co-cultures.
    Döpper S; Wilflingseder D; Prodinger WM; Stiegler G; Speth C; Dierich MP; Stoiber H
    Eur J Immunol; 2003 Aug; 33(8):2098-107. PubMed ID: 12884283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein-Barr virus-carrying B cells.
    Tremblay M; Meloche S; Sekaly RP; Wainberg MA
    J Exp Med; 1990 May; 171(5):1791-6. PubMed ID: 2159052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.